Clinical Trial Update: A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II trial updates the combination of GT90001 with KN046 in solid tumors, with phase progression in early development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GT90001
• KN046

Snippet

Sponsor: Suzhou Kintor Pharmaceutical Inc, | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN